openPR Logo
Press release

Anterior Uveitis Market: An Industry Case Study

02-05-2018 08:12 AM CET | Health & Medicine

Press release from: TMR - Research Report

/ PR Agency: TMR - Research Report

Uveitis is the inflammation of the uveal region of the eye, most commonly by an infection. Uvea is a group of pigmented and non pigmented tissues lying in the middle among the three layers that make the eye. Uvea again consists of three layers: iris, cilliary body and the choroid. The uvea is also known as the uveal tract in some medical circles, this tract is necessary for the nutrition of the eye and also to reduce glare of the light that enters by absorbing the light and reducing internal reflection within the eye. In addition the uvea also helps in generating the aqueous humour and in controlling the focus of the eye lens. The uvea also consists of lymphocytes and is therefore prone to respond to inflammation by developing lymphocytic infiltrates. Uveitis is therefore a condition that requires urgent response from an ophthalmologist and immediate treatment.

Read Report Overview: https://www.transparencymarketresearch.com/anterior-uveitis-market.html

Anterior Uveitis mainly includes iritis, which is known as the inflammation of the anterior chamber and the iris, and iridocyclitis, which is inflammation of the iris anterior chamber and the vitreous cavity. Anterior uveitis presents itself as redness of the eyes, irregular pupils, photophobia, blurred vision, eye pain/pressure, floaters visible to the patient, headaches, iridocyclitis induced cataract/glaucoma or synechia (attachment of iris to cornea or lens). The causative factors for uveitis has not yet been confirmed, however in half of the anterior uveitis cases a correlation was observed with the presence of HLA-B27 gene, which is a type of human leukocyte antigen (HLA) that increases the probability of an individual to contract uveitis by 15%. Anterior uveitis or acute anterior uveitis is the most common form of uveitis. Uveitis is primarily found to be systemic immune based; however possible causative factors in many cases also include infections from: Brucellosis, Leptospirosis, Lyme disease, Tuberculosis, Syphilis, Toxoplasmic chorioretinitis, Toxocariasis, or ocular histoplasmosis syndrome. Besides these drug interactions like rifabutin can also cause uveitis. Basically Uveitis occurs from the failed or hyperactive ocular immune response, this results in tissue destruction and inflammation, followed by buildup of mucus in extreme cases, hence the increased pressure.

Download Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2956

The treatment for uveitis is mainly symptom specific, with steroids and non-steroidal anti inflammatory drugs ins the form of eye drops, or oral medications. Corneal ulcers if present may pose as complications hence anti-inflammatory medication is prescribed only after ruling out this disorder. Cyclopegics or ciliary muscle relaxants are administered for diagnosis or certain surgical treatment if necessary. Anti TNF agents and other anti metabolite medications may prove helpful in cases of severe uveitis, e.g. infliximab.

Certain drugs like metformin, which is generally used as anti-diabetic drug has also been found to reduce inflammation in uveitis. Recent drugs like gevokizumab have undergone trials to for uveitis without infectious origin. The treatments given vary with the causative factor of uveitis, but overall the condition usually recedes after proper care and procedures are followed. In severe adverse cases, vision loss or cataract/glaucoma may occur, such cases however occur in very rare occasions. The incidence rate is as high as one in 4500 individuals globally according to a medical journal on ocular immunology. The incidence rates in developed countries of the west are higher than the developing countries in Asia and Africa. The market for anterior uveitis is therefore restricted to North American and European region, followed by Asia, South America and Rest of the World.

Purchase Anterior Uveitis Market Research Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=2956<ype=S

Some of the companies involved in the production of uveitis related drugs include: Novartis AG, Amdipharm Mercury Company Limited, Santen pharmaceuticals, etc.

About us:
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anterior Uveitis Market: An Industry Case Study here

News-ID: 930346 • Views: 252

More Releases from TMR - Research Report

Global Tissue Extraction System Market: Trends and Opportunities 2017 - 2025
Global Tissue Extraction System Market: Overview The global tissue extraction system market is foretold to display an impressive growth rate in the coming years. This could be owing to the need for tissue extraction or biopsy for cancer analysis after the patient has been suspected of carrying the disease. The procedure is extremely vital for diagnosing the disease. Thus, increasing prevalence of carcinogenic agents, compromised immunity levels, and rising incidence of
Neurology Sterile Injectable Market: Growth Factors, Applications, Regional Anal …
Neurology sterile injectables are generally administered to individuals suffering from pain linked to the nerves. Neuropathic pain injections are used to provide relief to these individuals. Neurology sterile injectable block the pain signal from reaching the brain. Neurological sterile injection can be administered at sympathetic nervous system, trigger points, dorsal roots, and peripheral nerves. The most commonly use neurological injectable used for nerve block are steroid injection, opioids, and local
External Fixator Devices Market: Global Survey and Trend Research
External fixator devices are used to stabilize and support long bone open fractures to help the patient carry body’s weight as well as movement. Schanz screws, connecting rods, and clamps are used in case of unipolar external fixators. Circulatory fixators include circular rings, wires, connecting rods, and struts. The external fixator devices provide rigid fixation along with fixed distraction of the fracture fragments. The major advantage of external fixator devices
Anorectal Preparations Market Trends, and Forecast 2017 - 2025
Anorectal preparations are products that contain a combination of an anti-inflammatory agent, or a pain reliever, and a local anesthetic as a suppository, or an ointment. External or internal hemorrhoids are treated by the topical application of anorectal preparations. Hemorrhoids are masses or lumps of tissue in the anus that contain enlarged blood vessels. The formation of hemorrhoids is due to an increase in abdominal pressure. Frequent constipation, which is

All 5 Releases


More Releases for Uveitis

Uveitis Treatment Market: Global Market Of Uveitis Disease Is Estimated To Reach …
Uveitis Treatment Market Precision Business Insights (PBI) in its report titled “Global Uveitis Treatment Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2017 and Forecast 2018-2027” assesses the market performance over 2018-2027. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period. Uveitis is swelling of the middle layer of the eye,
Uveitis Therapeutic and Disease Pipeline Review H1
Summary Uveitis is swelling and irritation of the uvea, the middle layer of the eye. Uveitis can affect one or both eyes. Uveitis can be caused by autoimmune disorders such as rheumatoid arthritis or ankylosing spondylitis, infection, or exposure to toxins. Symptoms include blurred vision, dark, floating spots in the vision, eye pain, redness of the eye and sensitivity to light. The predisposing factors include having an infection, an autoimmune or
Anterior Uveitis Market to Perceive Substantial Growth by 2024
Uveitis is the inflammation of the uveal region of the eye, most commonly by an infection. Uvea is a group of pigmented and non pigmented tissues lying in the middle among the three layers that make the eye. Uvea again consists of three layers: iris, cilliary body and the choroid. The uvea is also known as the uveal tract in some medical circles, this tract is necessary for the nutrition
Uveitis Treatment Market By Indication (Anterior uveitis, Intermediate uveitis, …
Uveitis is a combined condition of inflammation and swelling of the eyes. Uvea comprises of three parts Iris, ciliary body (small ring shape muscles behind iris and choroid), and choroid (it is the layer of tissue between retina and sclera), which decides eye color and helps eye in focusing and absorbing light. Uveitis can be caused by eye problems, autoimmune disease, HIV, multiple sclerosis, reactive arthritis, Kawasaki disease tuberculosis, and
Global Uveitis market Research Report - Pipeline Review, H2 2017
"The Latest Research Report Uveitis-Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" About Uveitis Market Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Uveitis-Pipeline Review, H2 2017, provides an overview of the Uveitis (Ophthalmology) pipeline landscape. Uveitis is swelling and irritation of the uvea, the middle layer of the eye. Uveitis can affect one or both eyes. Uveitis
Uveitis Treatment Market Worth US$ 847.8 Mn by 2024-End
The US$ 497 Mn uveitis treatment market is likely to expand at a stable CAGR of 6.5% over the next eight years. In 2017, the market is expected to witness nearly 6.7% Y-o-Y growth over 2016. During 2016-2024, Persistence Market Research predicts a positive growth outlook for the global uveitis treatment market, influenced by several growth drivers, restraints, trends, and opportunities. In its recently published report titled “Uveitis Treatment Market: Industry